UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy

Leukemia, Published online: 09 March 2020; doi:10.1038/s41375-020-0784-2UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy

Source: Leukemia - March 8, 2020 Category: Hematology Authors: Johana D íaz-Santa Roc ío Rodríguez-Romanos Gemma Osca Marta Pratcorona Ana Garrido Rosa Coll Carla Moret Lourdes Escoda Mar Tormo Inma Heras Montse Arnan Susanna Vives Olga Salamero Nat àlia Lloveras Joan Bargay Ant ònia Sampol David Cruz Antoni Gar Source Type: research